ArticleCancer management and research2020
Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer.
Linjun Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.